CH Biotech R&D Co., Ltd. (TPE:6534)
95.10
-0.10 (-0.11%)
Aug 15, 2025, 1:30 PM CST
CH Biotech R&D Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 364.31 | 476.39 | 463.29 | 465.42 | 291.5 | 100.16 | Upgrade
|
Depreciation & Amortization | 201.64 | 188.47 | 164.34 | 138.51 | 95.33 | 96.69 | Upgrade
|
Other Amortization | 1.29 | 1.29 | 1.48 | 1.18 | 1.32 | 1.51 | Upgrade
|
Loss (Gain) From Sale of Assets | -0.39 | -0.31 | -1.07 | -0.57 | -0.11 | -0.04 | Upgrade
|
Loss (Gain) on Equity Investments | 1.42 | 0.26 | 0.05 | - | - | - | Upgrade
|
Stock-Based Compensation | - | - | 1.24 | - | - | - | Upgrade
|
Other Operating Activities | -24.89 | -65.57 | 43.98 | 13.03 | 41.05 | 10.94 | Upgrade
|
Change in Accounts Receivable | -199.62 | -56.76 | -72.77 | 127.84 | -124.69 | -4.85 | Upgrade
|
Change in Inventory | -23.09 | -1.7 | 52.96 | -54.46 | -82.64 | 13.03 | Upgrade
|
Change in Accounts Payable | 0.83 | -2.66 | -0.36 | -11.09 | 13.94 | 4.39 | Upgrade
|
Change in Unearned Revenue | 0.1 | -0.14 | 0.17 | -0.05 | -0.15 | -0.48 | Upgrade
|
Change in Other Net Operating Assets | -5.78 | -0.81 | 5.85 | 19.17 | 28.81 | 11.55 | Upgrade
|
Operating Cash Flow | 326.23 | 538.44 | 659.15 | 698.97 | 264.36 | 232.91 | Upgrade
|
Operating Cash Flow Growth | -51.53% | -18.31% | -5.70% | 164.40% | 13.50% | -23.75% | Upgrade
|
Capital Expenditures | -161.9 | -588.42 | -113.68 | -113.89 | -71.92 | -107.88 | Upgrade
|
Sale of Property, Plant & Equipment | 0.39 | 0.32 | 2.61 | 1.23 | 0.23 | 0.04 | Upgrade
|
Cash Acquisitions | - | -3.55 | - | - | - | - | Upgrade
|
Sale (Purchase) of Intangibles | -4.15 | -1.54 | -1.04 | -3.26 | - | -0.87 | Upgrade
|
Investment in Securities | - | - | -29.4 | - | - | - | Upgrade
|
Other Investing Activities | -13.19 | -1.58 | -1.38 | -1.31 | 26.95 | 0.09 | Upgrade
|
Investing Cash Flow | -178.85 | -594.77 | -142.89 | -117.22 | -44.75 | -108.63 | Upgrade
|
Short-Term Debt Issued | - | 665.21 | 480 | 450 | 381 | 577 | Upgrade
|
Long-Term Debt Issued | - | 413.3 | 475.6 | 595.6 | - | 714 | Upgrade
|
Total Debt Issued | 935 | 1,079 | 955.6 | 1,046 | 381 | 1,291 | Upgrade
|
Short-Term Debt Repaid | - | -570.17 | -410 | -518 | -436 | -477 | Upgrade
|
Long-Term Debt Repaid | - | -546.51 | -620.69 | -776.34 | -124.85 | -807.3 | Upgrade
|
Total Debt Repaid | -848.08 | -1,117 | -1,031 | -1,294 | -560.85 | -1,284 | Upgrade
|
Net Debt Issued (Repaid) | 86.93 | -38.18 | -75.09 | -248.74 | -179.85 | 6.7 | Upgrade
|
Issuance of Common Stock | 0.17 | 0.1 | - | - | - | - | Upgrade
|
Common Dividends Paid | -421.48 | -369.05 | -473.77 | -126.63 | -42.21 | -88.44 | Upgrade
|
Other Financing Activities | 1.03 | 0.92 | 442.26 | - | - | - | Upgrade
|
Financing Cash Flow | -333.36 | -406.21 | -106.6 | -375.37 | -222.06 | -81.74 | Upgrade
|
Foreign Exchange Rate Adjustments | -5.48 | 1.46 | 0.25 | 2.64 | -0.55 | -0.52 | Upgrade
|
Net Cash Flow | -191.45 | -461.08 | 409.91 | 209.01 | -3 | 42.03 | Upgrade
|
Free Cash Flow | 164.33 | -49.98 | 545.47 | 585.08 | 192.43 | 125.03 | Upgrade
|
Free Cash Flow Growth | 37.95% | - | -6.77% | 204.04% | 53.91% | -25.83% | Upgrade
|
Free Cash Flow Margin | 9.76% | -3.06% | 36.01% | 40.80% | 18.89% | 17.80% | Upgrade
|
Free Cash Flow Per Share | 1.59 | -0.48 | 5.57 | 5.93 | 1.96 | 1.28 | Upgrade
|
Cash Interest Paid | 16.16 | 14.98 | 17.41 | 16.19 | 13.87 | 22.7 | Upgrade
|
Cash Income Tax Paid | 102.1 | 179.74 | 76.18 | 90.18 | 27.21 | 17.4 | Upgrade
|
Levered Free Cash Flow | 118.22 | -201.89 | 446.3 | 411.22 | 111.1 | 87.82 | Upgrade
|
Unlevered Free Cash Flow | 128.21 | -192.52 | 456.8 | 421.73 | 119.78 | 102.03 | Upgrade
|
Change in Working Capital | -227.57 | -62.07 | -14.14 | 81.4 | -164.74 | 23.64 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.